NPI: 1841223328 · DOTHAN, AL 36303 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 07/08/2006
Authorized official SCHULTZ, DONOVAN controls 20+ related entities in our dataset. Read more
| Authorized Official | SCHULTZ, DONOVAN (PRESIDENT) |
| NPI Enumeration Date | 07/08/2006 |
Other providers sharing the same authorized official: SCHULTZ, DONOVAN
| Provider | City | State | Total Paid |
|---|---|---|---|
| DIALYSIS CLINIC INC. | JACKSONVILLE | FL | $5.57M |
| DIALYSIS CLINIC INC. | ALBUQUERQUE | NM | $4.94M |
| DIALYSIS CLINIC INC. | CINCINNATI | OH | $4.29M |
| DIALYSIS CLINIC INC. | OMAHA | NE | $3.91M |
| DIALYSIS CLINIC INC. | SACRAMENTO | CA | $3.90M |
| DIALYSIS CLINIC INC. | PHILADELPHIA | PA | $2.95M |
| DIALYSIS CLINIC INC. | SACRAMENTO | CA | $2.60M |
| DIALYSIS CLINIC INC. | BOSTON | MA | $2.18M |
| DIALYSIS CLINIC INC. | NASHVILLE | TN | $2.11M |
| DIALYSIS CLINIC INC. | TUCSON | AZ | $1.92M |
| DIALYSIS CLINIC INC. | CORBIN | KY | $1.87M |
| DIALYSIS CLINIC INC. | GRANTS | NM | $1.69M |
| DIALYSIS CLINIC INC. | SKOWHEGAN | ME | $1.51M |
| DIALYSIS CLINIC, INC. | EAST LIVERPOOL | OH | $1.50M |
| DIALYSIS CLINIC INC. | CINCINNATI | OH | $1.50M |
| DIALYSIS CLINIC INC. | SYRACUSE | NY | $1.45M |
| DIALYSIS CLINIC INC. | NASHVILLE | TN | $1.44M |
| DIALYSIS CLINIC INC. | CHATTANOOGA | TN | $1.35M |
| DIALYSIS CLINIC, INC. | JACKSON | TN | $1.28M |
| DIALYSIS CLINIC INC. | LEBANON | TN | $1.02M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,524 | $533K |
| 2019 | 9,576 | $217K |
| 2020 | 8,599 | $147K |
| 2021 | 6,973 | $115K |
| 2022 | 6,238 | $124K |
| 2023 | 3,633 | $101K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 24,893 | 1,790 | $931K |
| J0882 | Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) | 1,102 | 293 | $164K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,733 | 917 | $103K |
| Q5105 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units | 610 | 50 | $13K |
| J1270 | Injection, doxercalciferol, 1 mcg | 8,608 | 804 | $7K |
| 83970 | 561 | 543 | $6K | |
| A4657 | Syringe, with or without needle, each | 8,576 | 974 | $4K |
| 84466 | 913 | 881 | $3K | |
| 82728 | 926 | 894 | $2K | |
| J1756 | Injection, iron sucrose, 1 mg | 160 | 37 | $1K |
| 83540 | 915 | 883 | $1K | |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 77 | 26 | $683.60 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 332 | 331 | $526.58 |
| 90662 | 70 | 60 | $374.09 | |
| 84100 | 25 | 25 | $42.30 | |
| G0008 | Administration of influenza virus vaccine | 27 | 27 | $0.00 |
| 83735 | 15 | 15 | $0.00 |